MetaCap

Who Owns Benitec Biopharma Stock?

NASDAQ: BNTCHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.92-0.225 (-2.76%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
96.19%
Institutional holders
123
  • Institutions 96.2%
  • Insiders 0.5%
  • Public and other 3.3%

Who owns Benitec Biopharma stock?

Institutional investors own about 96.2% of Benitec Biopharma's shares, spread across 123 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.55% of BNTC.

The largest institutional holders are Montanova Capital LLC (33.10%), Jupiter Topco LLC (7.10%) and Franklin Templeton, Inc. (6.91%). Together, the top 10 institutions control 75.9% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their BNTC positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of BNTC

Benitec Biopharma top institutional holders
InstitutionShares% HeldChange
Montanova Capital LLC11.55M33.10%0.0%
Jupiter Topco LLC2.48M7.10%+100.0%
Franklin Templeton, Inc.2.41M6.91%-0.0%
Adage Capital Partners GP L.L.C.2.12M6.08%0.0%
RA Capital Management, L.P.1.85M5.30%0.0%
Nantahala Capital Management, LLC1.68M4.81%+12.7%
Blackrock Inc.1.43M4.09%+1.5%
Vanguard Capital Management LLC1.04M2.97%+8.5%
Simplify Asset Management, Inc.1.00M2.87%-0.3%
Infinitum Asset Management, LLC 923.01K2.65%0.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of BNTC

Benitec Biopharma top fund holders
FundShares% Held
Simplify Exchange Traded Funds-Simplify Health Care ETF1.01M2.88%
Franklin Strategic Series-Franklin Biotechnology Discovery Fund995.15K2.85%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund649.54K1.86%
iShares Trust-iShares Russell 2000 ETF536.22K1.54%
Franklin Strategic Series-FRANKLIN SMALL CAP GROWTH FUND357.53K1.02%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund281.90K0.81%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund234.66K0.67%
iShares Trust-iShares Russell 2000 Value ETF189.19K0.54%
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund150.34K0.43%
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund122.04K0.35%

Frequently asked questions

Who is the largest shareholder of Benitec Biopharma?

Montanova Capital LLC is the largest institutional shareholder of BNTC, owning 33.10% of shares outstanding (11.55M shares) as of its latest 13F filing.

What percentage of Benitec Biopharma is owned by institutions?

Institutions own about 96.2% of BNTC shares and 96.7% of the public float.

How much of Benitec Biopharma do insiders own?

Insiders, such as officers and directors, own about 0.55% of BNTC shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related